Literature DB >> 32206595

Primary aldosteronism.

Sean M Wrenn1,2, Anand Vaidya3, Carrie C Lubitz1.   

Abstract

Primary aldosteronism (PA) is a common cause of secondary hypertension caused by excessive and inappropriate secretion of the hormone aldosterone from one or both adrenal glands. The prevalence of PA ranges from 10% in the general hypertensive population to 20% in resistant hypertension, yet only a small fraction of patients is diagnosed. Disease and symptom recognition, screening in indicated populations, multidisciplinary communication, and appropriate imaging and biochemical workup can identify patients who might benefit from effective and targeted treatment modalities. Effective treatments available include both surgical and medical approaches, usually dependent on the subtype of PA present. Our collective understanding of the pathophysiology of PA is expanded by recent developments in molecular biology and genetics, including understanding the specific somatic and germline mutations involved in pathogenesis. We review the pathophysiology, diagnostic workup, and treatment considerations for this disease process. 2020 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Conn’s syndrome; Primary aldosteronism (PA); adrenal adenoma; adrenal gland; endocrine; endocrine surgery

Year:  2020        PMID: 32206595      PMCID: PMC7082264          DOI: 10.21037/gs.2019.10.23

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  71 in total

1.  Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study.

Authors:  Stella Douma; Konstantinos Petidis; Michael Doumas; Panagiota Papaefthimiou; Areti Triantafyllou; Niki Kartali; Nikolaos Papadopoulos; Konstantinos Vogiatzis; Chrysanthos Zamboulis
Journal:  Lancet       Date:  2008-06-07       Impact factor: 79.321

2.  Dr. Conn Lives on: Insights Into Screening and Genetics of Primary Aldosteronism.

Authors:  Debbie L Stein; Jerry Yee
Journal:  Adv Chronic Kidney Dis       Date:  2019-03       Impact factor: 3.620

3.  Refining the Definitions of Biochemical and Clinical Cure for Primary Aldosteronism Using the Primary Aldosteronism Surgical Outcome (PASO) Classification System.

Authors:  B S Miller; A F Turcu; A T Nanba; D T Hughes; M S Cohen; P G Gauger; R J Auchus
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

Review 4.  Is Primary Aldosteronism Still Largely Unrecognized?

Authors:  Fabrizio Buffolo; Silvia Monticone; Jacopo Burrello; Martina Tetti; Franco Veglio; Tracy Ann Williams; Paolo Mulatero
Journal:  Horm Metab Res       Date:  2017-11-16       Impact factor: 2.936

5.  Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks.

Authors:  Kazutaka Nanba; Kei Omata; Celso E Gomez-Sanchez; Constantine A Stratakis; Andrew P Demidowich; Mari Suzuki; Lester D R Thompson; Debbie L Cohen; James M Luther; Lan Gellert; Anand Vaidya; Justine A Barletta; Tobias Else; Thomas J Giordano; Scott A Tomlins; William E Rainey
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

6.  The impact of Connshing's syndrome - mild cortisol excess in primary aldosteronism drives diabetes risk.

Authors:  Felix Beuschlein; Martin Reincke; Wiebke Arlt
Journal:  J Hypertens       Date:  2017-12       Impact factor: 4.844

7.  Primary aldosteronism with nonlocalizing imaging.

Authors:  Heather Wachtel; Sonia Bhandari; Robert E Roses; Debbie L Cohen; Scott O Trerotola; Douglas L Fraker
Journal:  Surgery       Date:  2018-11-07       Impact factor: 3.982

8.  Laparoscopic vs open adrenalectomy for benign adrenal neoplasm.

Authors:  D Hazzan; E Shiloni; D Golijanin; O Jurim; D Gross; P Reissman
Journal:  Surg Endosc       Date:  2001-08-16       Impact factor: 4.584

9.  Quality of life in patients with primary aldosteronism: gender differences in untreated and long-term treated patients and associations with treatment and aldosterone.

Authors:  Heike E Künzel; Konstantina Apostolopoulou; Anna Pallauf; Sabine Gerum; Katrin Merkle; Sebastian Schulz; Evelyn Fischer; Volker Brand; Martin Bidlingmaier; Stephan Endres; Felix Beuschlein; Martin Reincke
Journal:  J Psychiatr Res       Date:  2012-09-25       Impact factor: 4.791

10.  Review of surgical management of aldosterone secreting tumours of the adrenal cortex.

Authors:  D A Harris; I Au-Yong; P S Basnyat; G P Sadler; M H Wheeler
Journal:  Eur J Surg Oncol       Date:  2003-06       Impact factor: 4.424

View more
  2 in total

Review 1.  High Prevalence of Autonomous Aldosterone Production in Hypertension: How to Identify and Treat It.

Authors:  Taweesak Wannachalee; Leedor Lieberman; Adina F Turcu
Journal:  Curr Hypertens Rep       Date:  2022-02-14       Impact factor: 5.369

2.  Endocrine hypertension secondary to adrenal tumors: clinical course and predictive factors of clinical remission.

Authors:  Uriel Clemente-Gutiérrez; Rafael H Pérez-Soto; Juan D Hernández-Acevedo; Nicole M Iñiguez-Ariza; Enrique Casanueva-Pérez; Juan Pablo Pantoja-Millán; Mauricio Sierra-Salazar; Miguel F Herrera; David Velázquez-Fernández
Journal:  Langenbecks Arch Surg       Date:  2021-06-23       Impact factor: 3.445

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.